- Issuer ticker
-
CRL
- Reported as of
-
31 May 2024
- Net transaction value
-
+$1,022,607
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
04 Jun 2024, 16:17:30 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Flavia Pease
Key filing fact
Flavia Pease filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 04 Jun 2024.
Key facts
- This page summarizes Flavia Pease's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 16:17.
Change
- Previous filing in this sequence was filed on 29 May 2024.
- Current net transaction value: +$1,022,607.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,159
- Change %
- +28%
- Price
-
$0.000000
- Shares after
- 9,760
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $1,022,607
- Shares
- +4,906
- Change %
- Price
-
$208.44
- Shares after
- 4,906
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,906
- Exercise price
- $208.44
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes